Shots: Cerecor to receive up front as $4.5M in cash & $12.5M in Aytu preferred stock, which is approx. 1.4x LTM revenue, plus the assumption of debt The transaction will […]readmore
Tags : Aytu BioScience
Shots: Aytu acquires Innovus in cash & stock transaction making a total deal value up to $24M. Innovus to receive up to $8M shares in Aytu’s common stock as upfront […]readmore